Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Huib N. Caron
affiliation not provided to SSRN
Contact
affiliation not provided to SSRN
Email
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
36
TOTAL CITATIONS
0
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Mek Inhibition Causes BIM Stabilization and Increased Sensitivity to BCL-2 Family Member Inhibitors in RAS-MAPK-Mutated Neuroblastoma
Number of pages: 14
Posted: 26 Jul 2022
Thomas F. Eleveld
,
Lindy Vernooij
,
Linda Schild
,
Bianca Koopmans
,
Lindy K. Alles
,
Marli E. Ebus
,
Rana Dandis
,
Harm van Tinteren
, Huib N. Caron,
Jan Koster
,
M. M. van Noesel
,
Lieve G.A.M. Tytgat
,
Selma Eising
,
Rogier Versteeg
,
M. Emmy M. Dolman
and
Jan J. Molenaar
Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology,
affiliation not provided to SSRN
, University of Amsterdam - Department of Oncogenomics, Princess Máxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, University of Amsterdam - Department of Oncogenomics, Princess Maxima Center for Pediatric Oncology and Princess Maxima Center for Pediatric Oncology
Downloads
36
(1,236,159)
View PDF
Download
Abstract:
MEK, BCL-2, neuroblastoma, trametinib, navitoclax, venetoclax
Feedback